Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
THR-β agonist 4
Cat. No.:
OB0425LY-133
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
THR-β agonist 4 is a potent THR-β agonist that design to mimic the action of thyroid hormones.
Synonyms:
2673409-25-9; THR-beta agonist 4
CAS No.:
2673409-25-9
Compound CID:
157635927
Formula:
C16H11Cl2F2N5O6S
Formula Weight:
510.26
Specification
Target:
Thyroid hormone receptor
Pathway:
Vitamin D related/Nuclear receptor
Storage:
Storage at -20°C.
Applications:
THR-β agonist 4 is mainly used in the study of metabolic syndrome, obesity and related metabolic diseases. By activating THR-β receptors, it may help improve lipid metabolism and insulin sensitivity.
